JS Capital Management’s Cardlytics CDLX Stock Holding History

JS Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$165K	–	26
2023 Q3	$165K	Sell	1,000 -1,000	-50%	-$130K	0.02%	27
2023 Q2	$126K	Hold	2,000	–	–	0.02%	31
2023 Q1	$67.9K	Sell	2,000 -23,000	-92%	-$1.2M	0.01%	25
2022 Q4	$1.45M	Sell	25,000 -54,515	-69%	-$3.37M	0.38%	17
2022 Q3	$7.47M	Sell	79,515 -965	-1%	-$137K	1.82%	16
2022 Q2	$18M	Sell	80,480 -220	-0.3%	-$73.7K	2.96%	13
2022 Q1	$44.4M	Buy	80,700 +38,700	+92%	+$23.4M	3.45%	6
2021 Q4	$27.8M	Buy	42,000 +7,000	+20%	+$5.35M	1.26%	16
2021 Q3	$29.4M	Sell	35,000 -9,921	-22%	-$10.1M	1.7%	9
2021 Q2	$57M	Sell	44,921 -2,379	-5%	-$2.68M	2.76%	5
2021 Q1	$51.9M	Sell	47,300 -6,805	-13%	-$8.99M	2.68%	7
2020 Q4	$77.2M	Sell	54,105 -3,700	-6%	-$3.95M	3.7%	6
2020 Q3	$40.8M	Buy	57,805 +5,761	+11%	+$4.19M	2.11%	6
2020 Q2	$36.4M	Sell	52,044 -2,366	-4%	-$1.37M	2.75%	6
2020 Q1	$19M	Buy	54,410 +8,910	+20%	+$6.31M	2.39%	13
2019 Q4	$28.6M	Buy	45,500 +33,000	+264%	+$16.1M	3.3%	7
2019 Q3	$4.19M	Buy	+12,500	New	+$4.01M	0.57%	24

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

JS Capital Management's CDLX Position: Q4 2023 in Review

JS Capital Management sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 1,000 shares — an estimated $165K sold.

JS Capital Management first reported a position in CDLX in Q3 2019 and held it in 17 quarters. The position peaked at $77.2M in Q4 2020. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

JS Capital Management reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
JS Capital Management sold 1,000 Cardlytics shares in Q4 2023, an estimated $165K.
JS Capital Management first reported a position in Cardlytics in Q3 2019 and held it in 17 quarters.
JS Capital Management's Cardlytics position peaked at $77.2M in Q4 2020.
124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on JS Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.